
United States · Health startup
Supersapiens develops a real-time glucose monitor aimed at enhancing energy, exercise, and recovery through personalized glucose insights.
Funding reportedLast round: Seed
Supersapiens develops a real-time glucose monitor aimed at enhancing energy, exercise, and recovery through personalized glucose insights.
Their glucose monitoring system provides continuous data on metabolic performance, helping individuals optimize their training and competition efforts. The company serves athletes, exercisers, and those focused on recovery, enabling them to tailor their training and nutrition strategies based on metabolic data. Founded by Phil Southerland, a pioneer in continuous glucose monitoring technology, Supersapiens is dedicated to helping users perform at their best.
Funding, as reported
Supersapiens filed one raise, $1.2M in all. Filings say how much was sold and to how many investors; they never name the investors.
What they build
Known for
hardwarehealth careglucose trend analysisconsumersglucose stabilityperformance analyticsabbott libre senseenergy management systemsports & recreationinformation technology & servicesmobile appmetabolic healthreal-time glucose dataenergy managementsports nutritionhospital & health care
Built with from their website
Google Tag ManagerAmazon CloudFrontGoogle WorkspaceCloudFlareViewport MetaGoogle PlayVarnishWebflow HostingGoogle MeetWeglot
Mobile FriendlyOpen GraphjQueryStripeRecharge PaymentsSlackGoogle AnalyticsHTTP/3
Add your raise, your deck and your story, and put Supersapiens in front of investors. Or tell us what we have wrong.